Ecolab upgraded by Seaport Research Partners with a new price target
$ECL
Package Goods/Cosmetics
Consumer Discretionary
Seaport Research Partners upgraded Ecolab from Neutral to Buy and set a new price target of $290.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/21/2025 | $290.00 | Neutral → Buy | Seaport Research Partners |
| 4/16/2025 | $230.00 | Overweight → Equal Weight | Wells Fargo |
| 3/24/2025 | $270.00 | Buy → Neutral | Redburn Atlantic |
| 1/28/2025 | $263.00 → $280.00 | Equal-Weight → Overweight | Morgan Stanley |
| 12/17/2024 | $279.00 → $290.00 | Market Perform → Outperform | BMO Capital Markets |
| 11/4/2024 | $276.00 | Buy → Neutral | UBS |
| 10/18/2024 | $235.00 → $310.00 | Hold → Buy | Jefferies |
| 8/13/2024 | $270.00 | Overweight | Wells Fargo |
The board of directors of Ecolab Inc. has appointed Marion Gross, previously Executive Vice President and Global Chief Supply Chain Officer at McDonalds, to the Ecolab board as an independent director and member of the Compensation & Human Capital Management Committee and the Safety, Health & Environment Committee, effective May 7, 2025. Following her appointment, Ms. Gross was elected to the board at today's Ecolab Annual Meeting of Stockholders. "I am delighted to welcome an exceptional global leader of Marion's experience and expertise to our board of directors," said Christophe Beck, Ecolab chairman and chief executive officer. "Marion's executive leadership at one of the world's most
Ecolab Inc. announced today at its annual meeting of stockholders that the slate of thirteen director nominees named in the company's proxy statement was elected for a one-year term ending at its annual meeting of stockholders in May 2026. In other business during today's meeting, stockholders approved on an advisory basis the compensation of the named executive officers disclosed in the company's proxy statement, ratified the appointment of PricewaterhouseCoopers LLP as Ecolab's independent registered public accounting firm for 2025 and approved amendments to Ecolab's restated certificate of incorporation to limit the liability of certain officers as permitted by Delaware Law. The final
The board of directors of Ecolab Inc. has appointed Michel Doukeris, Chief Executive Officer of AB InBev, to the Ecolab board as an independent director, effective February 20, 2025. "Michel's experience as the CEO of a major global company and his deep knowledge of complex operations, world-class branding of innovative products and winning in consumer industries make him a tremendous addition to our board of directors," said Christophe Beck, Ecolab chairman and chief executive officer. "His proven ability to lead international teams to strong business results in both developed and developing markets, along with his commitment to elevating food safety and addressing water scarcity challeng
4 - ECOLAB INC. (0000031462) (Issuer)
4 - ECOLAB INC. (0000031462) (Issuer)
3 - ECOLAB INC. (0000031462) (Issuer)
The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.65 per common share, to be paid July 15, 2025, to shareholders of record at the close of business on June 17, 2025. Ecolab has paid cash dividends on its common stock for 88 consecutive years. About Ecolab A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on more than a century of innovation, Ecolab has annual sales of $16 billion, employs approximately 48,000 associates and operates in more than 170 countries around t
Ecolab will host a live webcast to discuss its 2025 first quarter results. A news release containing first quarter results is expected to be issued before market open on April 29, 2025. Details for the public webcast are as follows: TIME: 1:00 p.m. Eastern Time DATE: Tuesday, April 29, 2025 DURATION: One hour LOCATION: www.ecolab.com/investor ARCHIVE: A replay of the webcast and supplemental data will be available on Ecolab's website. About Ecolab A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the r
The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.65 per common share, to be paid April 15, 2025, to shareholders of record at the close of business on March 18, 2025. Ecolab has paid cash dividends on its common stock for 88 consecutive years. About Ecolab A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on more than a century of innovation, Ecolab has annual sales of $16 billion, employs approximately 48,000 associates and operates in more than 170 countries around
Seaport Research Partners upgraded Ecolab from Neutral to Buy and set a new price target of $290.00
Wells Fargo downgraded Ecolab from Overweight to Equal Weight and set a new price target of $230.00
Redburn Atlantic downgraded Ecolab from Buy to Neutral and set a new price target of $270.00
Ecolab Inc. will host its 2025 Investor Day on Thursday, September 4, starting at 8:00 a.m. (CT) in Eagan, MN. Christophe Beck chairman and chief executive officer, Scott Kirkland chief financial officer, and other members of the Ecolab senior leadership team will provide an in-depth review of the company's strategy, growth drivers, and financial objectives. The event will include formal presentations, Q&A sessions, a leadership luncheon, and interactive sessions showcasing the company's latest innovations. To register to attend the event in person, please contact Ecolab's Investor Relations department. As space will be limited, a live webcast of the presentation will be available via the
Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania. The new facility is designed to support biopharma customers with applications and process development for the purification of biotherapeutic molecules, providing comprehensive technical support to biopharmaceutical companies and contract manufacturers operating from small-scale to full commercial production. This new development location is well positioned in the Eastern U.S., close to many large pharmaceutical operations and a hub of bioprocessing innovation. The lab is equipped with high-throughput process development tools and manufacturing scale chromatography
Ecolab's 2024 Growth & Impact Report details record year of business performance by helping deliver $9.1B in cumulative customer value, save enough water for 781M people and protect 1.7B people from illnesses Ecolab Inc., a global sustainability leader offering water, hygiene, and infection prevention solutions, continues to grow fast by growing its impact and team while creating substantial customer value. Released today, Ecolab's 2024 Growth & Impact Report documents the company's performance and ongoing progress toward its 2030 Positive Impact ambitions, including a newly included impact of cumulative total value delivered through the company's services and solutions. The report reveal
4 - ECOLAB INC. (0000031462) (Issuer)
4 - ECOLAB INC. (0000031462) (Issuer)
4 - ECOLAB INC. (0000031462) (Issuer)
8-K/A - ECOLAB INC. (0000031462) (Filer)
8-K - ECOLAB INC. (0000031462) (Filer)
10-Q - ECOLAB INC. (0000031462) (Filer)
SC 13G/A - ECOLAB INC. (0000031462) (Subject)
SC 13D/A - ECOLAB INC. (0000031462) (Subject)
SC 13G/A - ECOLAB INC. (0000031462) (Subject)